Vaccines Global Market To Reach Value Of About $86 Billion In 2025

8 Nov, 2021

The vaccines market consists of sales of vaccines and related services. This industry includes establishments that produce anti-infective vaccines, autoimmunity vaccines and vaccines for cancer and other diseases. Vaccines create antibody-antigen reaction that helps in attaining resistance to the disease-causing organism. Vaccines include recombinant vaccines, conjugate vaccines, live attenuated vaccines, inactivated vaccines, toxoid vaccines and others.

Global Vaccines Market Size And Drivers:

The global vaccines market is expected to decline from $56.02 billion in 2020 to $55.97 billion in 2021 at a compound annual growth rate (CAGR) of -0.1%. The slow decline is mainly due to the outbreak of COVID-19 that has led to deferment of immunocompromised treatments. The vaccines market is expected to reach $85.93 billion in 2025 at a CAGR of 11.3%. Rising awareness on immunization and vaccination benefits in emerging markets is consistently driving the global vaccines market growth.

Request For A Sample For The Global Vaccines Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2556&type=smp

Trends In The Global Vaccines Market

The vaccines market has been witnessing multiple strategic initiatives and mergers and acquisitions in the recent years. Top companies in the market are strategically acquiring start-ups and mid-sized companies to broaden products and services. For instance, in February 2019, Bharat Biotech acquired Chiron Behring Vaccines, a clinical biotechnology company, one of the leading manufacturers of rabies vaccines across the globe. Similarly, in October 2018, Emergent BioSolutions, a multinational specialty biopharmaceutical company, acquired PaxVax for $270 million, and Sanofi acquired Protein Sciences for $650 million. Companies in the industry are increasingly realigning their portfolios and pursuing profitable inorganic growth opportunities. Additionally, M&A interest is also being fueled by stronger corporate balance sheets, liquid debt markets, and continued favorable interest rates globally.

Global Vaccines Market Segments:
The global vaccines market is further segmented –
By Type: Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)
By Technology: Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines
By Route of Administration: Intramuscular (IM), Subcutaneous (SC), Oral, Others
By Valance: Monovalent, Multivalent
By Distribution Channel: Institutional Sale, Hospital Pharmacies, Retail Pharmacies
By Geography: The global vaccines market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Vaccines Market At:

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Vaccines Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides vaccines market overviews, analyzes and forecasts market size and growth for the global vaccines market, vaccines market share, vaccines market players, vaccines market segments and geographies, vaccines market’s leading competitors’ revenues, profiles and market shares. The vaccines market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.